KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Cost of Revenue (2016 - 2025)

Opko Health (OPK) has disclosed Cost of Revenue for 16 consecutive years, with $84.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 14.7% year-over-year to $84.4 million, compared with a TTM value of $400.9 million through Dec 2025, down 18.94%, and an annual FY2025 reading of $400.9 million, down 18.94% over the prior year.
  • Cost of Revenue was $84.4 million for Q4 2025 at Opko Health, down from $101.8 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $650.6 million in Q4 2022 and bottomed at -$152.4 million in Q3 2023.
  • Average Cost of Revenue over 5 years is $133.6 million, with a median of $107.4 million recorded in 2025.
  • The sharpest move saw Cost of Revenue skyrocketed 2986.33% in 2022, then tumbled 218.87% in 2023.
  • Year by year, Cost of Revenue stood at $21.1 million in 2021, then surged by 2986.33% to $650.6 million in 2022, then decreased by 27.65% to $470.7 million in 2023, then crashed by 78.97% to $99.0 million in 2024, then dropped by 14.7% to $84.4 million in 2025.
  • Business Quant data shows Cost of Revenue for OPK at $84.4 million in Q4 2025, $101.8 million in Q3 2025, and $107.4 million in Q2 2025.